Navigation Links
IlluminOss Medical Receives ISO 13485 Certification
Date:2/23/2009

Company with Innovative Technology for the Minimally Invasive Treatment of Bone Fractures Achieves Significant Milestone in CE Mark Approval Pathway

EAST PROVIDENCE, R.I., Feb. 23 /PRNewswire/ -- IlluminOss Medical Inc., a medical device company developing the innovative IlluminOss(TM) Photodynamic Bone Stabilization System for orthopedic surgery, today announced that it had received an ISO 13485 Certificate of Registration issued by BSI (British Standards Institute). This certification indicates that IlluminOss has implemented a quality system that conforms to the exacting International Organization for Standardization (ISO) standards for medical devices and is one of the key regulatory requirements for a CE Mark in the European Union as well as other international markets.

ISO 13485 is an internationally recognized standardization system which defines standards for the design, development, production and distribution of medical devices. It ensures conformity with specified quality controls in the development of safe and effective devices.

According to Bob Rabiner, Founder and President of IlluminOss Medical, "ISO 13485 certification represents a major milestone for IlluminOss and patients worldwide. We believe that our minimally invasive technology will fundamentally improve the treatment of hundreds of thousands of bone fractures by driving much earlier restoration of functionality, improving the durability of orthopedic repairs, decreasing pain and reducing scarring."

About IlluminOss Medical Inc.

IlluminOss Medical is a privately held, early-stage medical device company dedicated to the development of minimally invasive orthopedic systems for the stabilization and treatment of bone fractures. The IlluminOss Photodynamic Bone Stabilization System utilizes a photodynamic (light-curable) polymer system intended to eliminate the need for traditional, inconvenient and painful methods of bone fixation with external pins, plates and screws. The Company is currently developing the IlluminOss Photodynamic Bone Stabilization System for small bones such as fractures of the hands, wrists, clavicle and arms. It is anticipated that the IlluminOss Photodynamic Bone Stabilization System will also have applications in the spine and long bones.

Founded in 2007, IlluminOss is headquartered in East Providence, RI. For more information about IlluminOss Medical, please visit www.illuminoss.com.

    Company Contact:               Media Contact:
    Bob Rabiner                    Stephen Sandler
    (401) 714-0008 ext. 207        (508) 358-7206 ext. 202
    rrabiner@illuminoss.com        ssandler@vmark.net


'/>"/>
SOURCE IlluminOss Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Environmental Tectonics Corporations BioMedical Divisions Hyperbaric Chambers Address U.S. President Obamas Initiative to Computerize Medical Records
2. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Monoplace Hyperbaric Chambers
3. TechniKroms Biopharmaceutical Equipment Operations to be Integrated With Asahi Kasei Medical
4. SPO Medical Appoints New US Sales Rep Groups
5. Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon
6. Hong Kong Biotech Company, Filligent, Announces CE Certification of Its Revolutionary, Anti-Infective Medical Face Mask, the BioMask
7. American Institute for Medical and Biological Engineering Appoints Dr. Gualberto Ruano to College of Fellows
8. Cordex Pharma Forms Heart Failure Medical Advisory Board
9. Former SADMERC Medical Directors Join OrthoCare Innovations as Medical and Scientific Advisory Board Members and Strategic Advisors
10. The Holtorf Medical Group and Yan Center for Corrective & Cosmetic Surgery Tap 5W Public Relations
11. Informed Medical Communications Appoints New Vice President, Information Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... , April 27, 2016 ... NSK) (OTCPink: NSKQB) ( Frankfurt : ... ihre Pressemitteilung vom 13. August 2015 die Genehmigung ... Finanzen um zusätzliche 200.000.000 Einheiten auf 400.000.000 Einheiten ... zu bringen. Davon wurden 157.900.000 Einheiten mit dem ...
(Date:4/27/2016)... Virgin Islands (PRWEB) , ... April 27, 2016 ... ... Company Ltd. (d/b/a Biohaven) is pleased to announce the appointment of John Tilton as ... was an Executive Director and one of the founding commercial leaders responsible for ...
(Date:4/27/2016)... MD (PRWEB) , ... April 27, 2016 , ... ... Greg Lamka, PhD to its Scientific Advisory Board. Dr. Lamka will assist PathSensors ... plant pathogen detection. , PathSensors deploys the CANARY® test platform for the ...
(Date:4/27/2016)... ... 2016 , ... Global Stem Cells Group CEO Benito Novas announced ... of GSCG affiliate Kimera Labs in Miami. , In 2004, Ross received his Ph.D. ... for hematologic disorders and the suppression of graft vs. host disease (GVHD) under UM ...
Breaking Biology Technology:
(Date:3/15/2016)... JERUSALEM , March 15, 2016 ... Jerusalem , the technology-transfer company of the Hebrew University, ... developer of remote sensing technology of various human biological ... funding, raising $2.0 million from private investors. ... technology, based on the detection of electromagnetic emissions from ...
(Date:3/11/2016)... 11, 2016 http://www.apimages.com ) - --> ... is available at AP Images ( http://www.apimages.com ) - ... used to produce the new refugee identity cards. DERMALOG will be ... CeBIT in Hanover next week.   --> ... be used to produce the new refugee identity cards. DERMALOG will ...
(Date:3/10/2016)... BLUE BELL, Pa. , March 10, 2016   ... U.S. Customs and Border Protection (CBP) is testing ... in San Diego to help identify ... United States . The test, designed to help determine ... outdoor, pedestrian environment, began in February and will run until ...
Breaking Biology News(10 mins):